Folia Health Announces Primary Immunodeficiencies (PI) as Second Condition of Focus at the IDF National Conference

Boston, MA, June 21, 2019

Folia Health, the digital health company that enables patients and caregivers to use their observations to get the right healthcare, has announced the launch of primary immunodeficiencies (PI) as their second condition. PI diseases affect 500,000 people across the United States, and were the original inspiration for Folia, as the founder’s family is affected by the condition.

“Through our experience working with the cystic fibrosis community, we have learned that there is an immense need to bring the voices of patients & caregivers back to the clinic in an organized way, so that every patient gets the right care, every time,” said Nell Meosky Luo, Founder and CEO of Folia Health. “As we transition from our pilot phase and begin to add new communities to the Folia family, we’re excited to start work in PI.”

According to the Immune Deficiency Foundation, which is holding its bi-annual conference in Washington D.C. June 20-22, 2019, individuals with PI often face challenges in receiving specialized healthcare and proper diagnosis and treatment.

About Folia Health:  At Folia Health, we believe patients and their families have the power to transform care. Through Folia, you can track symptoms, behaviors, treatments, and more, and use these observations to achieve the best care possible for yourself or your loved ones. Folia is enabling precision in healthcare, with a little help from the people who care most.


Nell Meosky Luo